![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 5
Zeitschriftenartikel
Schwarz, J.; Werner, C.; Steurer, M.; Spengler, U.; Wedemeyer, H.; Hahn, T. von; Stremmel, W.; Pathil-Warth, A.; Berg, T.; Engelmann, C.; Seybold, U.; Schott, E.; Blessin, U.; Malek, N.; Lauer, U. und Berg, C.
(2017):
High SVR 12 rates following treatment with direct acting antiviral agents (DAA) in a German multicentre cohort of HCV/HIV-1 coinfected patients on the transplant waiting list with advanced liver cirrhosis.
In: Journal of Hepatology, Bd. 66, Nr. 1:
S526-S526
Schwarze-Zander, C.; Draenert, R.; Lehmann, C.; Stecher, M.; Boesecke, C.; Sammet, S.; Wasmuth, J. C.; Seybold, U.; Gillor, D.; Wieland, U.; Kümmerle, T.; Strassburg, C. P.; Mankertz, A.; Eis-Hübinger, A. M.; Jäger, G.; Fätkenheuer, G.; Bogner, J. R.; Rockstroh, J. K. und Vehreschild, J. J.
(2017):
Measles, mumps, rubella and VZV: importance of serological testing of vaccine-preventable diseases in young adults living with HIV in Germany.
In: Epidemiology and infection, Bd. 145, Nr. 2: S. 236-244
Seybold, U.; Wagener, J.; Jung, J. und Sammet, S.
(2016):
Multidrug-resistant organisms among refugees in Germany: we need evidence-based care, not fear-based screening.
In: Journal of Hospital infection, Bd. 92, Nr. 3: S. 229-231
Bader, A.; Stemberger, M.; Spannagl, M.; Seybold, U. und Gülberg, V.
(2016):
Outcome of People with Haemophilia (PWH) During the Course of Treatment with Novel Hepatitis C Drugs.
In: Haemophilia, Bd. 22: S. 46
Zeder, A. J.; Hilge, R.; Schrader, S.; Bogner, J. R. und Seybold, U.
(2016):
Medium-grade tubular proteinuria is common in HIV-positive patients and specifically associated with exposure to tenofovir disoproxil Fumarate.
In: Infection, Bd. 44, Nr. 5: S. 641-649